Colorado § 17-1-113.4 Opioid treatment for a person in custody - definitions

Colorado Statutes

§ 17-1-113.4 — Opioid treatment for a person in custody - definitions

Colorado § 17-1-113.4

Title 17Corrections

Art.Department of Corrections

This text of Colorado § 17-1-113.4 (Opioid treatment for a person in custody - definitions) is published on Counsel Stack Legal Research, covering Colorado primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Colo. Rev. Stat. § 17-1-113.4 (2026).

Text

(1)A correctional facility or private contract prison may make available opioid agonists and opioid antagonists to a person in custody with an opioid use disorder. The correctional facility or private contract prison is strongly encouraged to maintain the treatment of the person throughout the duration of the person's incarceration, as medically necessary.

(2)(a) Qualified medication administration personnel may, in accordance with a written physician's order, administer opioid agonists and opioid antagonists for the treatment of an opioid use disorder pursuant to subsection (1) of this section.

(b)As funding and supplies allow, if a person in custody is treated for an opioid use disorder pursuant to this section, the correctional facility or private contract prison shall off

Free access — add to your briefcase to read the full text and ask questions with AI

(1) A
correctional facility or private contract prison may make available opioid agonists
and opioid antagonists to a person in custody with an opioid use disorder. The
correctional facility or private contract prison is strongly encouraged to maintain
the treatment of the person throughout the duration of the person's incarceration,
as medically necessary.

(2) (a) Qualified medication administration personnel may, in accordance
with a written physician's order, administer opioid agonists and opioid antagonists
for the treatment of an opioid use disorder pursuant to subsection (1) of this section.

(b) As funding and supplies allow, if a person in custody is treated for an
opioid use disorder pursuant to this section, the correctional facility or private
contract prison shall offer the person, upon release from the facility, at least two
doses of an opioid reversal medication, in a form approved by the federal drug
administration, and provide education to the person about the appropriate use of
the medication.

(3) A correctional facility or private contract prison may contract with
community-based health providers for the implementation of this section.

(3.5) Nothing in this section imposes civil or criminal liability on a state law
enforcement agency or law enforcement officer when ordinary care is used in the
administration or provision of an opioid reversal medication in cases when an
individual appears to be experiencing an opioid overdose.

(4) As used in this section, unless the context otherwise requires:

(a) Opioid agonist means a full or partial agonist that is approved by the
federal food and drug administration for the treatment of an opioid use disorder.

(b) Opioid antagonist means naltrexone, an opioid reversal medication, or
any similarly acting drug used for the treatment of an opioid use disorder that is not
a controlled substance and that is approved by the federal food and drug
administration for the treatment of an opioid use disorder.

Legislative History

Source: L. 2020: Entire section added, (HB 20-1017), ch. 288, p. 1422, � 1, effective September 14. L. 2021: (2) and (4)(b) amended and (3.5) added, (SB 21-137), ch. 362, p. 2382, � 28, effective June 28.